Long-Term Use of Crisaborole Ointment Once Daily in Adults, Children, and Infants With Mild-to-Moderate Atopic Dermatitis. A Phase 3, Randomized, Double-Blind, Vehicle Controlled Study to Evaluate the Efficacy and Safety of Maintenance Treatment and Flare Reduction with Crisaborole Ointment, 2%, Once Daily Over 52 Weeks in Pediatric and Adult Participants (Ages 3 Months and Older) with Mild-to-Moderate Atopic Dermatitis, who Responded to Twice Daily Crisaborole Ointment, 2%, Treatment.